Characterization of liver involvement in defects of cholesterol biosynthesis: Long‐term follow‐up and review
- 3 December 2004
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 132A (2) , 144-151
- https://doi.org/10.1002/ajmg.a.30426
Abstract
Inborn defects of cholesterol biosynthesis are a group of metabolic disorders presenting with mental retardation and multiple congenital anomalies (MCA/MR syndromes). Functional and structural liver involvement has been reported as a rare (2.5–6%) complication of the Smith–Lemli–Opitz syndrome (SLOS) (OMIM: #270400) and it has not been fully characterized. Here, we report on a long‐term follow‐up study of four patients with SLOS, and one case with lathosterolosis (OMIM: #607330) who presented with liver disease and underwent an extensive diagnostic work‐up. Reports of liver involvement in cholesterol biosynthesis defects are reviewed. Two main different patterns of liver involvement emerged: progressive cholestasis, and stable isolated hypertransaminasemia. In our series, the first pattern was found in two patients with SLOS and one with lathosterolosis, and the second in two SLOS cases. Cholestasis was associated with early lethality and normal serum γ‐glutamyl‐transferase (GGT) levels in SLOS, while possible prolonged survival and high GGT levels were seen in lathosterolosis. Hepatic fibrosis was present in both conditions. Liver biopsy performed in one of our SLOS patients with isolated hypertransaminasemia, showed only mild hydropic degeneration of the hepatocytes. The presence of liver involvement in 16% of the SLOS patients diagnosed at our Center suggests that this complication might have been underestimated in previously reported cases, possibly overshadowed by the severity of multiple malformations. Fetal hepatopathy, cholestasis, and isolated hypertransaminasemia can occur also in other disorders of cholesterol biosynthesis, such as mevalonic aciduria (OMIM: +251170), desmosterolosis (OMIM: #602398), Conradi–Hünermann syndrome (OMIM: #302960), Greenberg dysplasia (OMIM: #215140), and Pelger–Huët homozygosity syndrome (#169400). This group of inherited disorders should be considered in the differential diagnosis of patients presenting with liver disease associated with developmental delay and/or multiple malformations. Periodic liver function evaluations are recommended in these patients.Keywords
This publication has 29 references indexed in Scilit:
- Congenital abnormalities reported in Pelger-Huet homozygosity as compared to Greenberg/HEM dysplasia: highly variable expression of allelic phenotypesJournal of Medical Genetics, 2003
- Lathosterolosis, a Novel Multiple-Malformation/Mental Retardation Syndrome Due to Deficiency of 3β-Hydroxysteroid-Δ5-DesaturaseAmerican Journal of Human Genetics, 2002
- INBORNERRORS OFSTEROLBIOSYNTHESISAnnual Review of Genomics and Human Genetics, 2001
- Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutationsEuropean Journal of Human Genetics, 1999
- Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.Journal of Medical Genetics, 1998
- Severe Smith‐Lemli‐Opitz syndrome with prolonged survival and lipid abnormalitiesAmerican Journal of Medical Genetics, 1995
- Abnormal bile acids in the Smith‐Lemli‐Opitz syndromeAmerican Journal of Medical Genetics, 1994
- Apparent Smith–Lemli–Opitz syndrome in a child with a previously undescribed form of mucolipidosis not involving the neuronsAmerican Journal of Medical Genetics, 1990
- Female external genitalia and müllerian duct derivatives in a 46,XY infant with the Smith‐Lemli‐Opitz syndromeAmerican Journal of Medical Genetics, 1987
- Smith‐Lemli‐Opitz syndrome‐type II: Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethalityAmerican Journal of Medical Genetics, 1987